Germline BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia : Identification of three novel mutations (CROSBI ID 606761)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Musani, Vesna ; Levačić Cvok, Mirela ; Sušac, Ilona ; Sabol, Maja ; Ozretić, Petar ; Car, Diana ; Eljuga, Damir ; Levanat, Sonja
engleski
Germline BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia : Identification of three novel mutations
Breast cancer is the most commonly diagnosed cancer inwomen after non-melanoma skin cancer, and is the leading cause of cancerrelated deaths in Croatia. Ovarian cancer is in the fifth place, both in incidenceand mortality. About 5−15% of breast cancer and 10% of ovarian cancer casesare hereditary, and germline mutations inBRCA1andBRCA2genes accountfor the majority of hereditary breast and ovarian cancers. The purpose of thisstudy was to estimate the incidence and spectrum of pathogenic mutations inBRCA1/2genes in high risk women in Croatia. This study was funded by TheTerry Fox Run 2009 donation and supported by The Terry Fox Foundation andCroatian League Against Cance
Germline mutations ; BRCA1/BRCA2 ; breast/ovarian cancer
Abstracts of the 22nd Biennial Congress of the European Association for Cancer Research.
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
S274-S275.
2012.
nije evidentirano
objavljeno
10.1016/S0959-8049(12)71739-2
Podaci o matičnoj publikaciji
European journal of cancer. Supplement (1990)
EACR
Amsterdam: Elsevier
1359-6349
Podaci o skupu
22nd Biennial Congress of the European Association for Cancer Research (22 ; 2012)
poster
07.07.2012-10.07.2012
Barcelona, Španjolska
Povezanost rada
Temeljne medicinske znanosti